| No. of patients | P | OR (95%CI) |
---|
DD ≤ 30 days (87,896) | DD > 30 days (120,926) |
---|
Unfavorable outcome | 4518 (5.1) | 7044 (5.8) | P < 0.001 | 0.876 (0.843,0.910) |
Died |
Non-TB death | 655 (0.8) | 1425 (1.2) | P < 0.001 | 1.614 (1.470,1.771) |
TB death | 199 (0.2) | 434 (0.4) | P < 0.001 | 1.587 (1.342,1.878) |
Treatment failed | 478 (0.5) | 768 (0.6) | P = 0.006 | 1.174 (1.047,1.316) |
Not evaluated | 3185 (3.6) | 4417 (3.6) | P = 0.716 | 1.009 (0.963,1.057) |
Favorable outcome | 83,378 (94.9) | 113,882 (94.2) | Reference | Reference |
- DD Diagnostic delay, TB Tuberculosis, PTB Pulmonary tuberculosis
- Favorable outcome including “cured” and “treatment completed”
- Unfavorable outcome is defined as “died”, “treatment failed” and “not evaluated”
- “Died” means a patient died for whatever reason during the study period. It combined with TB death and non-TB death. Non-TB death means that TB was not the main cause of death. “Treatment failed” means anyone whose bacteriological result remains positive after 5 months treatment. “Not evaluated” includes cases who are lost to follow-up and whose treatment outcome is unknown during the study period